China Universal Asset Management »

Fulcrum Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $100k 8.8k 11.31
2024-09-30 $43k 12k 3.57
2024-06-30 $45k 7.3k 6.20
2024-03-31 $113k 12k 9.44
2023-12-31 $48k 7.2k 6.75
2023-09-30 $7.1k 1.6k 4.44
2023-06-30 $2.7k 810 3.30
2023-03-31 $2.4k 836 2.85
2022-12-31 $3.9k 529 7.28
2022-09-30 $4.0k 487 8.21

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Point72 Asset Management
Siren
First Turn Management
Balyasny Asset Management
D. E. Shaw & Co
Ikarian Capital
ADAR1 Capital Management

View all funds holding Fulcrum Therapeutics